Jeremy Juang

Stanford University — United States

Immunology and Microbiology · Life Sciences

11h-index1.2kcitations12works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(10), T-cell and B-cell Immunology(4), vaccines and immunoinformatics approaches(4), Herpesvirus Infections and Treatments(3), RNA Interference and Gene Delivery(3)

Publications12 total

Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8+ T Lymphocytes
Immunity·2015· 288 citedOpen Access
Peptide-MHC heterodimers show that thymic positive selection requires a more restricted set of self-peptides than negative selection
The Journal of Experimental Medicine·2010· 59 citedOpen Access
A role for “self” in T-cell activation
Seminars in Immunology·2007· 55 citedOpen Access
Vaccination with a DNA Vaccine Encoding Herpes Simplex Virus Type 1 VP22 Linked to Antigen Generates Long-Term Antigen-Specific CD8-Positive Memory T Cells and Protective Immunity
Human Gene Therapy·2004· 58 cited
In Situ Hybridization in Cancer and Normal Tissue
Humana Press eBooks·2003· 4 cited
Boosting with recombinant vaccinia increases HPV-16 E7-Specific T cell precursor frequencies and antitumor effects of HPV-16 E7-Expressing sindbis virus replicon particles
Molecular Therapy·2003· 43 cited
Enhancing DNA Vaccine Potency by Combining a Strategy to Prolong Dendritic Cell Life with Intracellular Targeting Strategies
The Journal of Immunology·2003· 86 citedOpen Access
Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins
Journal of Clinical Investigation·2003· 154 citedOpen Access
Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins
Journal of Clinical Investigation·2003· 159 citedOpen Access
Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes.
PubMed·2003· 64 cited
Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe
Vaccine·2003· 192 cited
Improving DNA Vaccine Potency by Linking Marek's Disease Virus Type 1 VP22 to an Antigen
Journal of Virology·2002· 86 citedOpen Access

Frequent Co-authors

Chien‐Fu Hung(8), Liangmei He(8), T.‐C. Wu(7), Tae Woo Kim(4), Morris Ling(4), Mark M. Davis(3), J. Marie Hardwick(3), Peter Ebert(2), Cheng‐Tao Lin(2), Sharad Kumar(2), David A. Boyd(2), Jeong Won Kim(2), Michelle Krogsgaard(2), Wong Yu(1), Ning Jiang(1), Brian Kidd(1), Sabina Müller(1), Peder J. Lund(1), Keishi Adachi(1), Tiffany Tse(1)